Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Bond Pet Foods Inc. currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. Both of these matters are being processed within 1 distinct art unit, indicating a highly specialized and concentrated focus for the company's current intellectual property. The alignment of the pending work within the Biotechnology & Pharmaceuticals technology area suggests a deep pursuit of patent protection for its biotech innovations. By focusing on 1 distinct art unit, the company can streamline its responses to meet the specific scientific and legal standards of that division.
The prosecution of these matters is handled by 1 distinct examiner, ROBINSON, HOPE A. As the busiest examiner for the company, ROBINSON, HOPE A is responsible for 2 pending office actions. This means that the company's current pending workload is under the review of this individual. For the practitioner, this concentration emphasizes the importance of understanding the specific examination patterns of ROBINSON, HOPE A, as this examiner's decisions will directly impact the outcome of the pending office actions currently in the portfolio. The reliance on 1 distinct examiner for the entirety of the pending portfolio creates a centralized point of contact for all current prosecution negotiations.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, HOPE A | 2 | 67.7% | +43.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19030061 | COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN | ROBINSON, HOPE A | — |
| 17427046 | COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN | ROBINSON, HOPE A | — |
| Art Unit | Apps |
|---|---|
| 1652 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19030061 | COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 17427046 | COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN | ROBINSON, HOPE A | 1652 | §112DP | Non-Final OA | — | Pending | Jul 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBond Pet Foods Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Hope A Robinson has the most, with 2 of Bond Pet Foods Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
